Skip to main content
. 2021 Jun 23;54(3):87–96. doi: 10.1267/ahc.21-00007

Fig. 5.

Fig. 5.

Histone modifications in the biology of pituitary tumors. Metabolic reprogramming promotes histone acetylation, mainly H3K9, leading to upregulation of TERT, a key downstream effector in the progression of pituitary tumors.